Bordet Scientific Publications

Bordet Scientific Publications

  • A preoperative window-of-opportunity study of oral SERD, imlunestrant, in newly diagnosed ER-positive, HER2-negative early breast cancer: Results from EMBER-2 Study.

  • Auteurs Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, Carter S, Bidard FC, Fasching PA, Aftimos P, Wheatley D, Hamilton E, Aft R, Kulkarni S, Schmid P, Bhave M, Ismail-Khan R, Karacsonyi C, Estrem ST, Nguyen B, Ozbek U, Yuen E, Rodrik-Outmezguine V, Ciruelos E
  • Auteurs (entité) AFTIMOS PHILIPPE
  • Revue Clin Cancer Res
  • Date de publication 2024-10
A preoperative window-of-opportunity study of oral SERD, imlunestrant, in newly diagnosed ER-positive, HER2-negative early breast cancer: Results from EMBER-2 Study.
  • Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
  • Auteurs (entité) WITTNEBEL SEBASTIAN
  • Revue Ann Hematol
  • Date de publication 2024-10
Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
  • Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
  • Auteurs (entité) ANDREOZZI FABIO
  • Revue Ann Hematol
  • Date de publication 2024-10
Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
  • Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
  • Auteurs (entité) LEWALLE PHILIPPE
  • Revue Ann Hematol
  • Date de publication 2024-10
Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
  • Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
  • Auteurs (entité) SALAROLI ADRIANO
  • Revue Ann Hematol
  • Date de publication 2024-10
Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications